Deep-vein thrombosis in patients with multiple myeloma receiving first-line thalidomide-dexamethasone therapy

被引：112

作者：

Cavo, M ^{[1
]}

Zamagni, E ^{[1
]}

Cellini, C ^{[1
]}

Tosi, P ^{[1
]}

Cangini, D ^{[1
]}

Cini, M ^{[1
]}

Valdrè, L ^{[1
]}

Palareti, G ^{[1
]}

Masini, L ^{[1
]}

Tura, S ^{[1
]}

Baccarani, M ^{[1
]}

机构：

[1] Inst Hematol & Med Oncol Seragnoli, I-40138 Bologna, Italy

来源：

BLOOD | 2002年 / 100卷 / 06期

关键词：

D O I：

10.1182/blood-2002-06-1674

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2272 / 2273

页数：2

共 50 条

[21] Thalidomide-dexamethasone versus melphalan-prednisolone as first line treatment in elderly patients with multiple myeloma:: An interim analysis.
Ludwig, H
Drach, J
Tóhová, E
Gisslinger, H
Jaksic, B
Linkesch, W
Hajek, R
Greil, R
Fridrik, M
Labar, B
Zojer, N
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 569S - 569S
[22] Thalidomide-dexamethasone versus melphalan-prednisolone as first line treatment in elderly patients with multiple myeloma:: An interim analysis.
Ludwig, H
Drach, J
Tóthová, E
Gisslinger, H
Linkesch, W
Jaksic, B
Fridik, M
Thaler, J
Lang, A
Hajek, R
Zojer, N
Greil, R
Kuhn, I
Hinke, A
Labar, B
BLOOD, 2005, 106 (11) : 231A - 231A
[23] Efficacy and tolerability of combination thalidomide-dexamethasone in multiple myeloma patients with refractory disease
Hatjiharissi, E
Gerotziafas, G
Papaioannou, M
Bakaloudi, V
Tokmaktsis, A
Kaloutsi, V
Christakis, J
Zervas, K
INTERNATIONAL JOURNAL OF CANCER, 2002, : 104 - 104
[24] THALIDOMIDE-DEXAMETHASONE (THALDEX) AS SALVAGE THERAPY FOR MULTIPLE MYELOMA PATIENTS RELAPSING AFTER HIGH DOSE THERAPY AND AUTOPBSCT
Charlinski, G.
Barwicka, M.
Wiater, E.
Dwilewicz-Trojaczek, J.
Wiktor-Jedrzejczak, W.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 262 - 263
[25] CYCLOPHOSPHAMIDE THALIDOMIDE DEXAMETHASONE (CTD) AS FIRST-LINE THERAPY IN MULTIPLE MYELOMA. EXPERIENCE IN A HOSPITAL IN LIMA, PERU
Del Carpio-Jayo, D.
Untama-Flores, J.
Navarro-Cabrera, J.
HAEMATOLOGICA, 2012, 97 : 628 - 628
[26] Venous Thromboembolism Prophylaxis with Aspirin for Multiple Myeloma Patients Receiving Thalidomide Combination As First-Line Treatment
Crusoe, Edvan de Queiroz
Massarenti, Mariana
Almeida, Manuella
Cury, Priscilla
Higashi, Fabiana
Vieira, Luiza
Rossato, Marina
Peres, Ana Lucia
Castro, Anna Carolina
Silva, Ana Luiza
Hungria, Vania T. M.
BLOOD, 2014, 124 (21)
[27] First-line thalidomide-dexamethasone therapy in preparation for auto-SCT in young patients (<61 years) with symptomatic multiple myeloma (Retraction of vol 36, pg 193, 2005)
Abdelkefi, A.
Torjman, L.
Romdhane, N. Ben
Ladeb, S.
El Omri, H.
Othman, T. Ben
Elloumi, M.
Bellaj, H.
Lakhal, A.
Jeddi, R.
Aissaoui, L.
Saad, A.
Hsairi, M.
Boukef, K.
Dellagi, K.
Abdeladhim, A. Ben
BONE MARROW TRANSPLANTATION, 2009, 43 (11) : 893 - 893
[28] EFFECT OF THALIDOMIDE-DEXAMETHASONE THERAPY ON BONE MARROW ANGIOGENESIS IN NEWLY DIAGNOSED MULTIPLE MYELOMA
Ladeb, S.
Mrad, K.
Abdelkefi, A.
Torjemane, L.
Safra, I.
Hdiji, S.
Ben Romdhane, N.
Mdhaffer, M.
El Omri, H.
Ben Othman, T.
Ben Romdhane, K.
Ben Abdeladhim, A.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 512 - 512
[29] Bortezomib(Velcade®)-thalidomide-dexamethasone versus thalidomide-dexamethasone to treat multiple myeloma patients progressing or relapsing after autologous transplantation: the MMVAR trial
Garderet, L.
Iacobelli, S.
Moreau, P.
Onida, F.
Koenecke, C.
Scheid, C.
Doyen, C.
Bouko, Y.
Ketterer, N.
Masszi, T.
Crawley, C.
Hajek, R.
Linkesch, W.
Ludwig, H.
Harousseau, J. L.
Michallet, M.
de Witte, T.
Niederwieser, D.
Gahrton, G.
Morris, T. C. M.
BONE MARROW TRANSPLANTATION, 2010, 45 : S33 - S33
[30] Thalidomide therapy and deep venous thrombosis in multiple myeloma
Rajkumar, SV
MAYO CLINIC PROCEEDINGS, 2005, 80 (12) : 1549 - 1551

← 1 2 3 4 5 →